Multi-Frequency RF Combined with Intense Pulsed Light Improves Signs and Symptoms of Dry Eye Disease Due to Meibomian Gland Dysfunction

References

• Shimazaki J. Definitions and diagnostic criteria of dry eye disease: historical overview and future directions. Invest Ophthalmol Vis Sci. 2018;59(14):DES7–DES12. doi:10.1167/iovs.17-23475
   PubMed Web of Science ®Google Scholar
• Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS II Introduction. Ocul Surf. 2017;15(3):269–275. doi:10.1016/j.jtos.2017.05.005
   PubMed Web of Science ®Google Scholar
• Sheppard JD, Nichols KK. Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape. Ophthalmol Ther. 2023;12(3):1397–1418. doi:10.1007/s40123-023-00669-1
   PubMed Web of Science ®Google Scholar
• Baudouin C, de la Maza MS, Amrane M, et al. One-year efficacy and safety of 0.1% cyclosporine a cationic emulsion in the treatment of severe dry eye disease. Eur J Ophthalmol. 2017;27(6):678–685. doi:10.5301/ejo.5001002
   PubMed Web of Science ®Google Scholar
• Cui D, Li G, Akpek EK. Autologous serum eye drops for ocular surface disorders. Curr Opin Allergy Clin Immunol. 2021;21(5):493–499. doi:10.1097/ACI.0000000000000770
   PubMed Web of Science ®Google Scholar
• Kaiserman I, Rabina G, Mimouni M, et al. The effect of therapeutic meibomian glands expression on evaporative dry eye: a prospective randomized controlled trial. Curr Eye Res. 2021;46(2):195–201. doi:10.1080/02713683.2020.1789663
   PubMed Web of Science ®Google Scholar
• Tauber J. A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction. Cornea. 2020;39(4):403–407. doi:10.1097/ICO.0000000000002235
   PubMed Web of Science ®Google Scholar
• Chan TYC, Chow SSW, Wan KHN, Yuen HKL. Update on the association between dry eye disease and meibomian gland dysfunction. Hong Kong Med J. 2019;25(1):38–47. doi:10.12809/hkmj187331
   PubMed Web of Science ®Google Scholar
• Wang D, Liu X, Hao X, et al. Effect of the meibomian gland squeezer for treatment of meibomian gland dysfunction. Cornea. 2018;37:1270–1278. doi:10.1097/ICO.0000000000001682
   PubMed Web of Science ®Google Scholar
• Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf. 2017;15(2):179–192. doi:10.1016/j.jtos.2017.01.006
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628. doi:10.1016/j.jtos.2017.05.006
   PubMed Web of Science ®Google Scholar
• Sharma A, Kroumpouzos G, Kassir M, et al. Rosacea management: a comprehensive review. J Cosmet Dermatol. 2022;21(5):1895–1904.
   PubMed Web of Science ®Google Scholar
• Viso S, Millán A, Rodríguez-Ares M. Rosacea-associated meibomian gland dysfunction- an epidemiological perspective. Eur Ophthalmic Rev. 2014;8:13–16. doi:10.17925/EOR.2014.08.01.13
   Google Scholar
• Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015;33(1):41–46. doi:10.1089/pho.2014.3819
   PubMed Web of Science ®Google Scholar
• Toyos R, Desai NR, Toyos M, Dell SJ. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: a randomized controlled study. PLoS One. 2022;17(6):e0270268. doi:10.1371/journal.pone.0270268
   PubMed Web of Science ®Google Scholar
• Yan X, Hong J, Jin X, et al. The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a multicenter, randomized controlled trial. Eye Contact Lens. 2021;47(1):45–53. doi:10.1097/ICL.0000000000000711
   PubMed Web of Science ®Google Scholar
• Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104–110. doi:10.1016/j.jtos.2018.11.004
   PubMed Web of Science ®Google Scholar
• Seo KY, Kang SM, Ha DY, Chin HS, Jung JW. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Cont Lens Anterior Eye. 2018;41(5):430–435. doi:10.1016/j.clae.2018.06.002
   PubMed Web of Science ®Google Scholar
• Suwal A, Hao JL, Zhou DD, Liu XF, Suwal R, Lu CW. Use of intense pulsed light to mitigate meibomian gland dysfunction for dry eye disease. Int J Med Sci. 2020;17(10):1385–1392. doi:10.7150/ijms.44288
   PubMed Web of Science ®Google Scholar
• Fishman HA, Periman LA, Shah AA. Real-time video microscopy of in vitro demodex death by intense pulsed light. Photobiomodul Photomed Laser Surg. 2020;38(8):472–476. doi:10.1089/photob.2019.4737
   PubMed Web of Science ®Google Scholar
• Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol. 2017;11:1167–1173. doi:10.2147/OPTH.S139894
   PubMed Web of Science ®Google Scholar
• Guo L, Kubat NJ, Isenberg RA. Pulsed radio frequency energy (PRFE) use in human medical applications. Electromagn Biol Med. 2011;30(1):21–45. doi:10.3109/15368378.2011.566775
   PubMed Web of Science ®Google Scholar
• Sadick NS, Malerich SA, Nassar AH, Dorizas AS. Radiofrequency: an update on latest innovations. J Drugs Dermatol. 2014;13(11):1331–1335.
   PubMed Web of Science ®Google Scholar
• Louis F, Fujii N, Katsuyama M, Okumoto S, Matsusaki M. Effects of radiofrequency and ultrasound on the turnover rate of skin aging components (skin extracellular matrix and epidermis) via HSP47-induced stimulation. Biochem Biophys Res Commun. 2020;:S0006-291X(20)30286–2. doi:10.1016/j.bbrc.2020.02.020
   Web of Science ®Google Scholar
• Araújo AR, Soares VP, Silva FS, Moreira Tda S. Radiofrequency for the treatment of skin laxity: mith or truth. An Bras Dermatol. 2015;90(5):707–721. doi:10.1590/abd1806-4841.20153605
   PubMed Web of Science ®Google Scholar
• Han JY, Park SY, Sunwoo JH, Kim JY, Tchah H, Lee H. Safety and efficacy of a low-level radiofrequency thermal treatment in an animal model of obstructive meibomian gland dysfunction. Lasers Med Sci. 2022;37(7):2907–2915. doi:10.1007/s10103-022-03559-3
   PubMed Web of Science ®Google Scholar
• Jaccoma EH, Litherland C, Jaccoma A, Ahmed A. Pellevé™ vs Lipiflow™ MGD-related dry eye treatment study: the ThermaLid™ procedure. Journal of Dry Eye and Ocular Surface Disease. 2018;1(1):e11–e21. doi:10.22374/jded.v1i1.2
   Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
   PubMed Web of Science ®Google Scholar
• Chester T, Garg SS, Johnston J, Ayers B, Gupta P. How can we best diagnose severity levels of dry eye disease: current perspectives. Clin Ophthalmol. 2023;17:1587–1604. doi:10.2147/OPTH.S388289
   PubMed Web of Science ®Google Scholar
• Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31(4):396–404. doi:10.1097/ICO.0b013e318239aaea
   PubMed Web of Science ®Google Scholar
• Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128(1):94–101. doi:10.1001/archophthalmol.2009.356
   PubMedGoogle Scholar
• Ghadessi M, Tang R, Zhou J, et al. A roadmap to using historical controls in clinical trials - by drug information association adaptive design scientific working group (DIA-ADSWG). Orphanet J Rare Dis. 2020;15(1):69. doi:10.1186/s13023-020-1332-x
   PubMed Web of Science ®Google Scholar
• Viele K, Berry S, Neuenschwander B, et al. Use of historical control data for assessing treatment effects in clinical trials. Pharm Stat. 2014;13(1):41–54. doi:10.1002/pst.1589
   PubMed Web of Science ®Google Scholar
• Craig JP, Chen YH, Turnbull PRK. Prospective trial of intense pulsed Light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56(3):1965–1970. doi:10.1167/iovs.14-15764
   PubMed Web of Science ®Google Scholar
• Wilson MW, Dailey RA. Eyelid malposition. In: Cioffi GA, editor. The Devers Manual: Ophthalmology for the Health Care Professional. Baltimore: Williams & Wilkins; 1997:27–35.
   Google Scholar
• Zelickson BD, Kist D, Bernstein E, et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device: a pilot study. Arch Dermatol. 2004;140(2):204–209. doi:10.1001/archderm.140.2.204
   PubMedGoogle Scholar
• Javate RM, Cruz RT Jr, Khan J, Trakos N, Gordon RE. Nonablative 4-MHz dual radiofrequency wand rejuvenation treatment for periorbital rhytides and midface laxity. Ophthalmic Plast Reconstr Surg. 2011;27(3):180–185. doi:10.1097/IOP.0b013e3181fe8e5a
   PubMed Web of Science ®Google Scholar
• Cuerda-Galindo E, Díaz-Gil G, Palomar-Gallego MA, Linares-GarcíaValdecasas R. Increased fibroblast proliferation and activity after applying intense pulsed light 800-1200 nm. Ann Anat. 2015;198:66–72. doi:10.1016/j.aanat.2014.11.005
   PubMed Web of Science ®Google Scholar
• Huang J, Luo X, Lu J, et al. IPL irradiation rejuvenates skin collagen via the bidirectional regulation of MMP-1 and TGF-β1 mediated by MAPKs in fibroblasts. Lasers Med Sci. 2011;26(3):381–387. doi:10.1007/s10103-010-0870-1
   PubMed Web of Science ®Google Scholar